Calithera Biosciences (NASDAQ:CALA) Shares Break Above 50-Day Moving Average – What’s Next?

Calithera Biosciences, Inc. (NASDAQ:CALA)’s stock price crossed above its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of $0.00 and traded as high as $0.0001. Calithera Biosciences shares last traded at $0.0001, with a volume of 163 shares.

Calithera Biosciences Price Performance

Calithera Biosciences Company Profile

Calithera Biosciences, Inc was a clinical-stage biotechnology company focused on developing therapies for cancer and other serious diseases by targeting cellular metabolism and the tumor microenvironment. The company was headquartered in South San Francisco, California, and its research programs were aimed at disrupting metabolic pathways that cancer cells use to grow and resist treatment.

Its lead investigational product was telaglenastat (CB-839), an oral inhibitor of glutaminase, an enzyme involved in glutamine metabolism.